Literature DB >> 3489741

Immunopathology of cutaneous human lupus erythematosus defined by murine monoclonal antibodies.

B S Andrews, A Schenk, R Barr, G Friou, G Mirick, P Ross.   

Abstract

Skin biopsy specimens obtained from involved skin from sixteen patients with systemic and discoid lupus erythematosus were studied. Murine monoclonal antibodies with a biotin-avidin-horseradish peroxidase staining system were used. The findings consisted of a marked reduction in the number of epidermal Langerhans cells defined by surface antigens, reduced HLA-DR (Ia-like) antigens on the surface of dermal capillary endothelium, and mononuclear cell infiltrates characterized by a predominance of helper T lymphocytes and an increase in the number of mononuclear phagocytic cells. B lymphocytes were rarely identified. The number of T lymphocytes within the dermis correlated inversely with both the number of HLA-DR-positive epidermal Langerhans cells (p less than 0.01) and the HLA-DR staining of dermal capillary endothelium (p less than 0.01). These findings suggest that a T lymphocyte-mediated immune response associated with a reduction in Langerhans cells and capillary endothelium HLA-DR antigens is involved in the inflammatory process of lupus erythematosus skin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3489741     DOI: 10.1016/s0190-9622(86)70196-5

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

Review 1.  Immunopathologic studies of cutaneous lupus erythematosus.

Authors:  T T Provost; M Reichlin
Journal:  J Clin Immunol       Date:  1988-07       Impact factor: 8.317

2.  Langerhans Cells Maintain Local Tissue Tolerance in a Model of Systemic Autoimmune Disease.

Authors:  Jennifer K King; Rachael L Philips; Anna U Eriksson; Peter J Kim; Ramesh C Halder; Delphine J Lee; Ram Raj Singh
Journal:  J Immunol       Date:  2015-06-12       Impact factor: 5.422

3.  Lupus erythematosus panniculitis: an immunohistochemical study.

Authors:  V Riccieri; A Sili Scavalli; A Spadaro; E Taccari; A Zoppini
Journal:  Clin Rheumatol       Date:  1994-12       Impact factor: 2.980

4.  Assessment of Response to B-Cell Depletion Using Rituximab in Cutaneous Lupus Erythematosus.

Authors:  Rita Quelhas da Costa; M Elena Aguirre-Alastuey; David A Isenberg; Amanda M Saracino
Journal:  JAMA Dermatol       Date:  2018-12-01       Impact factor: 10.282

Review 5.  Pathophysiology of cutaneous lupus erythematosus.

Authors:  Julie H Lin; Jan P Dutz; Richard D Sontheimer; Victoria P Werth
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 10.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.